BioNTech at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

BioNTech brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on safer gene transfer and faster cell manufacturing. One topic is making expression cassettes in integrating vectors less likely to disturb nearby genes, another is virus-free CAR T production from resting T cells in two days.

OrganizationESGCT 2026 Attendance
BioNTech
Mainz, Germany
biontech.com
Biotech
Immunotherapy company developing mRNA vaccines and cancer medicines, with a cell and gene therapy unit working on CAR-T cells and virus-free cell engineering.
Poster
Wed Oct 28
1:30pm–3:30pm
Increased genomic safety of expression cassettes in integrating vectors
Non viral delivery
Poster
Thu Oct 29
2:00pm–4:00pm
InstaCAR: two-day virus-free CAR-T manufacturing from resting T cells
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BioNTech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction